Event Newsletter

Affimed GmbH

  • Bioscience
Im Neuenheimer Feld 582
Heidelberg 69120
+49 6221 674360
+49 6221 6743649 (fax)
  • About

    Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK- and T-cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases.